InsidersTradesSigma
Follow the 셀리드 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 셀리드 has logged 4 public disclosures. Market capitalisation: €51.3bn. The latest transaction was reported on 6 May 2026 (Purchase). Among the most active insiders: 강창율. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
셀리드 是一家在健康和制药领域运营的公司，在 XKRX 市场上市。该公司专注于开发医疗保健领域的创新解决方案。